Evidence map›Paper›PMID 31164613›Full record

ReviewMethods and protocols2019

Cell-Free Metabolic Engineering: Recent Developments and Future Prospects.

Hye Jin Lim, Dong-Myung Kim

Abstract readReview
In one paragraph

Review in Methods and protocols, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. BeyondChemical reviews · 2025
    Review
  3. Review
  4. Article
  5. Rewiring cell-free metabolic flux inSynthetic biology (Oxford, England) · 2023
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Methods to reduce variability inSynthetic and systems biotechnology · 2019
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hye Jin LimDepartment of Chemical Engineering and Applied Chemistry, Chungnam National University, Daejeon 34134, Korea. yhjysy@naver.com.
Dong-Myung KimDepartment of Chemical Engineering and Applied Chemistry, Chungnam National University, Daejeon 34134, Korea. dmkim@cnu.ac.kr.

Funding

National Research Foundation of Korea 2015M3D3A1A01064878National Research Foundation of Korea 2016M1A5A1027465
6 · The paper itself

Abstract

Due to the ongoing crises of fossil fuel depletion, climate change, and environmental pollution, microbial processes are increasingly considered as a potential alternative for cleaner and more efficient production of the diverse chemicals required for modern civilization. However, many issues, including low efficiency of raw material conversion and unintended release of genetically modified microorganisms into the environment, have limited the use of bioprocesses that rely on recombinant microorganisms. Cell-free metabolic engineering is emerging as a new approach that overcomes the limitations of existing cell-based systems. Instead of relying on metabolic processes carried out by living cells, cell-free metabolic engineering harnesses the metabolic activities of cell lysates in vitro. Such approaches offer several potential benefits, including operational simplicity, high conversion yield and productivity, and prevention of environmental release of microorganisms. In this article, we review the recent progress in this field and discuss the prospects of this technique as a next-generation bioconversion platform for the chemical industry.

Indexed as

bioconversion platformcell-free metabolic engineeringcell-free protein synthesis

Identifiers

PMID31164613
PMCPMC6632161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.